Skip to main content
Fig. 5 | Journal of Hematology & Oncology

Fig. 5

From: In vivo evaluation of CD38 and CD138 as targets for nanoparticle-based drug delivery in multiple myeloma

Fig. 5

In vivo biodistribution of CD38pep- and CD138pep-targeted nanoparticles loaded with a NIR dye. Nanoparticles targeted with CD38pep or CD138pep were prepared loaded with the NIR dye DiD, and their in vivo biodistribution was tested in a subcutaneous xenograft mouse model of myeloma. Mice were injected with H929 cells and tumors allowed to grow to a predetermined size before IV injection of nanoparticle formulations; 24 h after nanoparticle injection, the mice were killed, and the tumor and major organs were imaged (a, b). Tumors were digested, and uptake of the nanoparticles by the tumor cells was measured via flow cytometry (c). n ≥ 5 for all groups. Data represent means (± s.e.). Statistical significance represents comparison to nontargeted liposomes, *p ≤ 0.05, **p ≤ 0.005

Back to article page